
    
      Study Design:

      Prospective, multi-center, single-arm, open-label, Phase 3 clinical study to 3 years with
      extension up to 5 years

      Number of Subjects:

      Approximately 1,525 subjects will be enrolled into the study

      Study Population:

      Post-menarcheal, pre-menopausal women up to age 45 years, who are at risk for pregnancy and
      who desire a long-term intrauterine contraceptive for birth control will be eligible for this
      study.
    
  